Pan-PPAR agonist, bezafibrate, restores angiogenesis in hindlimb ischemia in normal and diabetic rats

International Journal of Peptides

Volumn 2012, Issue , 2012, Pages

  Khazaei, M ^a   Salehi, E ^a   Rashidi, B ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; NITRITE; TRIACYLGLYCEROL; VASCULOTROPIN; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CAPILLARY DENSITY; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; HINDLIMB; INSULIN DEPENDENT DIABETES MELLITUS; LIMB ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84868619604     PISSN: 16879767     EISSN: 16879775     Source Type: Journal    
DOI: 10.1155/2012/637212     Document Type: Article

References (29)

1. Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocrine Reviews 1999 20 5 649 688 (Pubitemid 30650602)
2. Willson T. M., Brown P. J., Sternbach D. D., Henke B. R., The PPARs: from orphan receptors to drug discovery Journal of Medicinal Chemistry 2000 43 4 527 550 (Pubitemid 30127149)
3. Tenenbaum A., Motro M., Fisman E. Z., Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons Cardiovascular Diabetology 2005 4 14
4. Fernandes-Santos C., Carneiro R. E., de Souza Mendonca L., Aguila M. B., Mandarim-de-Lacerda C. A., Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet Nutrition 2009 25 7-8 818 827
5. Tenenbaum A., Motro M., Fisman E. Z., Adler Y., Shemesh J., Tanne D., Leor J., Boyko V., Schwammenthal E., Behar S., Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients European Heart Journal 2005 26 19 2032 2038 (Pubitemid 41435721)
6. Tenenbaum A., Fisman E. Z., Boyko V., Benderly M., Tanne D., Haim M., Matas Z., Motro M., Behar S., Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate Archives of Internal Medicine 2006 166 7 737 741
7. Simons M., Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed? Journal of the American College of Cardiology 2005 46 5 835 837
8. Simons M., Angiogenesis: where do we stand now? Circulation 2005 111 12 1556 1566 (Pubitemid 40470653)
9. Biscetti F., Straface G., Pitocco D., Zaccardi F., Ghirlanda G., Flex A., Peroxisome proliferator-activated receptors and angiogenesis Nutrition, Metabolism and Cardiovascular Diseases 2009 19 11 751 759
10. Carmeliet P., Angiogenesis in health and disease Nature Medicine 2003 9 6 653 660 (Pubitemid 36749213)
11. Ferrara N., Vascular endothelial growth factor Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 6 789 791
12. Kerbel R. S., Tumor angiogenesis New England Journal of Medicine 2008 358 19 2039 2049 (Pubitemid 351656458)
13. Cook J. P., NO and angiogenesis Atherosclerosis Supplements 2003 4 4 53 60
14. Luque C. D., Vargas Robles H., Romo E., Rios A., Escalante B., The role of nitric oxide in the post-ischemic revascularization process Pharmacology and Therapeutics 2006 112 2 553 563 (Pubitemid 44486414)
15. Taniyama Y., Morishita R., Aoki M., Nakagami H., Yamamoto K., Yamazaki K., Matsumoto K., Nakamura T., Kaneda Y., Ogihara T., Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease Gene Therapy 2001 8 3 181 189 (Pubitemid 32186129)
16. Murohara T., Asahara T., Silver M., Bauters C., Masuda H., Kalka C., Kearney M., Chen D., Chen D., Symes J. F., Fishman M. C., Huang P. L., Isner J. M., Nitric oxide synthase modulates angiogenesis in response to tissue ischemia Journal of Clinical Investigation 1998 101 11 2567 2578 (Pubitemid 28270451)
17. Katayama A., Yamamoto Y., Tanaka K., Matsubara K., Sugitani M., Fujihara S., Harada S., Kaetsu Y., Yoshida A., Hisatome I., Fenofibrate enhances neovascularization in a murine ischemic hindlimb model Journal of Cardiovascular Pharmacology 2009 54 5 399 404
18. Panigrahy D., Kaipainen A., Huang S., Butterfield C. E., Barnés C. M., Fannon M., Laforme A. M., Chaponis D. M., Folkman J., Kieran M. W., PPAR agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition Proceedings of the National Academy of Sciences of the United States of America 2008 105 3 985 990 (Pubitemid 351282068)
19. Beckman J. A., Creager M. A., Libby P., Diabetes and atherosclerosis epidemiology, pathophysiology, and management Journal of the American Medical Association 2002 287 19 2570 2581 (Pubitemid 34517204)
20. Ferrara N., Vascular endothelial growth factor: molecular and biological aspects Current Topics in Microbiology and Immunology 1999 237 1 30 (Pubitemid 28554856)
21. Carmeliet P., Mechanisms of angiogenesis and arteriogenesis Nature Medicine 2000 6 4 389 395 (Pubitemid 30208155)
22. Kawasaki K., Smith R. S. Jr, Hsieh C. M., Sun J., Chao J., Liao J. K., Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis Molecular and Cellular Biology 2003 23 16 5726 5737 (Pubitemid 36951336)
23. Murohara T., Witzenbichler B., Spyridopoulos I., Asahara T., Ding B., Sullivan A., Losordo D. W., Isner J. M., Role of endothelial nitric oxide synthase in endothelial cell migration Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 5 1156 1161 (Pubitemid 29227632)
24. Fukumura D., Gohongi T., Kadambi A., Izumi Y., Ang J., Yun C. O., Buerk D. G., Huang P. L., Jain R. K., Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2604 2609 (Pubitemid 32209529)
25. Pozzi A., Capdevila J. V., PPARalpha ligands as antitumorigenic and antiangiogenic agents PPAR Research 2008 2008 8
26. Bishop-Bailey D., Peroxisome proliferator-activated receptor beta/delta goes vascular Circulation Research 2008 102 2 146 147 (Pubitemid 351651115)
27. Elkeles R. S., Diamond J. R., Poulter C., Dhanjil S., Nicolaides A. N., Mahmood S., Richmond W., Mather H., Sharp P., Feher M. D., Cardiovascular outcomes in type 2 diabetes: a double-blind placebo- controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park diabetes cardiovascular disease prevention (SENDCAP) study Diabetes Care 1998 21 4 641 648 (Pubitemid 28172949)
28. Ericsson C. G., Nilsson J., Grip L., Svane B., Hamsten A., Effect of bezafibrate treatment over five years on coronary plaques causing 20 to 50 diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]) American Journal of Cardiology 1997 80 9 1125 1129 (Pubitemid 27467397)
29. Biscetti F., Gaetani E., Flex A., Aprahamian T., Hopkins T., Straface G., Pecorini G., Stigliano E., Smith R. C., Angelini F., Castellot J. J., Pola R., Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPARgamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism Diabetes 2008 57 5 1394 1404